Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Neal

Showing results (41-50 of 302) with videos related to

Pageof 31
Sort By:
Social Science & Medicine (1982)|April 15, 2009
It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trialsJulia Wade, Jenny L Donovan, J Athene Lane, et al.
BMJ (Clinical Research Ed.)|April 24, 2010
Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous surveyGeorgios Lyratzopoulos, Josephine M Barbiere, David C Greenberg, et al.
The Prostate|October 1, 2009
The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic targetHayley C Whitaker, Anne Y Warren, Rosalind Eeles, et al.
Controlled Clinical Trials|May 22, 2003
Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT studyNicola Mills, Jenny L Donovan, Monica Smith, et al.
The Prostate|March 26, 2004
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancerKalipso Halkidou, Luke Gaughan, Susan Cook, et al.
BMC Bioinformatics|January 27, 2007
Missing channels in two-colour microarray experiments: combining single-channel and two-channel dataAndy G Lynch, David E Neal, John D Kelly, et al.
Journal of Clinical Epidemiology|April 12, 2011
Exploring treatment preferences facilitated recruitment to randomized controlled trialsNicola Mills, Jenny L Donovan, Julia Wade, et al.
BJU International|November 15, 2011
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populationsLih-Ming Wong, Richard Johnston, Naomi Sharma, et al.
The Prostate|May 7, 2008
Alterations in beta-catenin expression and localization in prostate cancerHayley C Whitaker, Joanne Girling, Anne Y Warren, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
Adhesion of lymphocytes to bladder cancer cells: the role of the alpha(E)beta(7) integrinJoanne Cresswell, Wai Keong Wong, Matthew J Henry, et al.
Pageof 31

Showing results (41-50 of 302) with videos related to

Sort By:
Pageof 31
Social Science & Medicine (1982)|April 15, 2009
It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trialsJulia Wade, Jenny L Donovan, J Athene Lane, et al.
BMJ (Clinical Research Ed.)|April 24, 2010
Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous surveyGeorgios Lyratzopoulos, Josephine M Barbiere, David C Greenberg, et al.
The Prostate|October 1, 2009
The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic targetHayley C Whitaker, Anne Y Warren, Rosalind Eeles, et al.
Controlled Clinical Trials|May 22, 2003
Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT studyNicola Mills, Jenny L Donovan, Monica Smith, et al.
The Prostate|March 26, 2004
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancerKalipso Halkidou, Luke Gaughan, Susan Cook, et al.
BMC Bioinformatics|January 27, 2007
Missing channels in two-colour microarray experiments: combining single-channel and two-channel dataAndy G Lynch, David E Neal, John D Kelly, et al.
Journal of Clinical Epidemiology|April 12, 2011
Exploring treatment preferences facilitated recruitment to randomized controlled trialsNicola Mills, Jenny L Donovan, Julia Wade, et al.
BJU International|November 15, 2011
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populationsLih-Ming Wong, Richard Johnston, Naomi Sharma, et al.
The Prostate|May 7, 2008
Alterations in beta-catenin expression and localization in prostate cancerHayley C Whitaker, Joanne Girling, Anne Y Warren, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
Adhesion of lymphocytes to bladder cancer cells: the role of the alpha(E)beta(7) integrinJoanne Cresswell, Wai Keong Wong, Matthew J Henry, et al.
Pageof 31